TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/24 17:02 | 3/5/24 | YMAB | Y-Mabs Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rajah Vignesh | NY | O | SVP,CHIE | S | -28 | 16.53 | 0 | -2 | -4 | 38 | D | ||||||||||||||
11/16/22 19:01 | 11/15/22 | YMAB | Y-Mabs Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rajah Vignesh | NY | O | SVP,CMO | P | 6 | 4.92 | 0 | 1 | 39 | 4 | I | ||||||||||||||
8/13/21 17:41 | 8/12/21 | YMAB | Y-Mabs Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rajah Vignesh | NY | O | SVP,CMO | P | 41 | 29.95 | 0 | 1 | 81 | 3 | I | ||||||||||||||
12/4/20 18:00 | 11/17/20 | YMAB | Y-Mabs Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rajah Vignesh | NY | O | SVP,CMO | P.m | 79 | 46.47 | 0 | 2 | 116 | 3 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |